Sattva Sukun Lifecare Limited has announced a board meeting on the outcome of its Rights Issue, which received only 40% subscription, netting ₹19.16 Cr against a target of ₹48 Cr. The company has prioritized fund allocation based on necessity, with ₹10 Cr for strategic investment in PavaPuri Export Pvt Ltd, ₹2 Cr for an existing subsidiary, ₹2.2 Cr for working capital, ₹3 Cr for expansion plans, ₹1.16 Cr for general corporate use, and ₹0.8 Cr for other specified purposes. Business plans will be phased as per available funds, reflecting a cautious approach to capital deployment.